Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Shimizu Y, Shiraishi A, et al. Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/CT. Liver Int. 2013;33:1085–91.

Article  PubMed  Google Scholar 

Malik V, Johnston C, Donohoe C, Claxton Z, Lucey J, Ravi N, et al. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. Clin Nucl Med. 2012;37:1152–8.

Article  PubMed  Google Scholar 

Raveenthiran S, Esler R, Yaxley J, Kyle S. The use of (68)Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46:2280–8.

Article  PubMed  Google Scholar 

Luciani A, Balducci L. Multiple primary malignancies. Semin Oncol. 2004;31:264–73.

Article  PubMed  Google Scholar 

Sturludottir M, Martling A, Carlsson S, Blomqvist L. Synchronous rectal and prostate cancer–the impact of MRI on incidence and imaging findings. Eur J Radiol. 2015;84:563–7.

Article  PubMed  Google Scholar 

Wu A, He S, Li J, Liu L, Liu C, Wang Q, et al. Colorectal cancer in cases of multiple primary cancers: clinical features of 59 cases and point mutation analyses. Oncol Lett. 2017;13:4720–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kichloo A, Amir R, Aljadah M, Wani F, Solanki S, Singh J, et al. FDG-PET versus PSMA-PET: a patient with prostate cancer. J Investig Med High Impact Case Rep. 2020;8:2324709620941313.

PubMed  PubMed Central  Google Scholar 

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338–44.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Jordanian Ministry of Health. Jordan Cancer Registry: cancer incidence in Jordan. 2018 [database on the Internet]. https://moh.gov.jo/ebv4.0/root_storage/ar/eb_list_page. Accessed 4 May 2023.

Pan SY, Huang CP, Chen WC. Synchronous/metachronous multiple primary malignancies: review of associated risk factors. Diagnostics. 2022;12:1940.

Dabir PD, Svanholm H, Christiansen JJ. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary. APMIS. 2018;126:494–500.

Article  CAS  PubMed  Google Scholar 

Lin C, Jin K, Hua H, Lin J, Zheng S, Teng L. Synchronous primary carcinomas of the rectum and prostate: Report of three cases. Oncol Lett. 2011;2:817–9.

PubMed  PubMed Central  Google Scholar 

Wu V, Sidiqi B, Kobritz M, Purchla J, Herman JM, Gamma NAL, et al. Synchronous prostate and rectal cancers across a large distributed healthcare system: implications for national accreditation program for rectal cancer (NAPRC) guidelines. J Clin Oncol. 2022;40:e15591-e.

Article  Google Scholar 

Agarwal A, Marcus C, Xiao J, Nene P, Kachnic LA, Subramaniam RM. FDG PET/CT in the management of colorectal and anal cancers. AJR Am J Roentgenol. 2014;203:1109–19.

Article  PubMed  Google Scholar 

Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. Metaanalysis of (68)Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology. J Nucl Med. 2019;60:786–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirmas N, Al-Ibraheem A, Herrmann K, Alsharif A, Muhsin H, Khader J, et al. [(68)Ga]PSMA PET/CT improves initial staging and management plan of patients with high-risk prostate cancer. Mol Imaging Biol. 2019;21:574–81.

Article  CAS  PubMed  Google Scholar 

Al-Ibraheem A, Abuhijla F, Salah S, Shahait M, Khader J, Mohamad I, et al. The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy. Nucl Med Commun. 2021;42:811–7.

Article  CAS  PubMed  Google Scholar 

Cerci JJ, Fanti S, Lobato EE, Kunikowska J, Alonso O, Medina S, et al. Diagnostic performance and clinical impact of (68)Ga-PSMA-11 PET/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA Study). J Nucl Med. 2022;63:240–7.

Article  CAS  PubMed  PubMed Central  Google Scholar